Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Asset Writedowns and Impairment (2022 - 2026)

ADC Therapeutics has reported Asset Writedowns and Impairment over the past 5 years, most recently at $1.5 million for Q1 2026.

  • Quarterly results put Asset Writedowns and Impairment at $1.5 million for Q1 2026, up 18.22% from a year ago — trailing twelve months through Mar 2026 was $2.5 million (up 24.55% YoY), and the annual figure for FY2025 was $2.3 million, up 50.46%.
  • Asset Writedowns and Impairment reached $1.5 million in Q1 2026 per ADCT's latest filing, up from $411000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.2 million in Q4 2022 and bottomed at $767.0 in Q3 2022.
  • Median Asset Writedowns and Impairment over the past 5 years was $446500.0 (2024), compared with a mean of $646285.7.
  • Peak annual rise in Asset Writedowns and Impairment hit 37432.27% in 2023, while the deepest fall reached 61.71% in 2023.
  • Over 5 years, Asset Writedowns and Impairment stood at $2.2 million in 2022, then crashed by 61.71% to $828000.0 in 2023, then crashed by 41.79% to $482000.0 in 2024, then decreased by 14.73% to $411000.0 in 2025, then skyrocketed by 258.39% to $1.5 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for ADCT at $1.5 million in Q1 2026, $411000.0 in Q4 2025, and $237000.0 in Q3 2025.